USA Biosimilars/follow-on-biologics Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Biosimilars/follow-on-biologics market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Biosimilars/follow-on-biologics market. Detailed analysis of key players, along with key growth strategies adopted by Biosimilars/follow-on-biologics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Synthon Pharmaceuticals

    • Teva Pharmaceutical Industries

    • Biogen idec

    • Hospira

    • Merck Serono (Merck)

    • Celltrion Biocon

    • Genentech (Roche)

    • LG Life Sciences

    • Novartis (Sandoz)

    By Type:

    • Human growth hormone

    • Erythropoietin

    • Monoclonal antibodies

    • Insulin

    • Interferon

    • Granulocyte-Colony Stimulating Factor

    • Others

    By End-User:

    • Blood disorders

    • Oncology diseases

    • Chronic and autoimmune diseases

    • Growth hormone deficiencies

    • Others

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Biosimilars/follow-on-biologics Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Biosimilars/follow-on-biologics Market Size and Growth Rate of Human growth hormone from 2016 to 2027

      • 1.3.2 USA Biosimilars/follow-on-biologics Market Size and Growth Rate of Erythropoietin from 2016 to 2027

      • 1.3.3 USA Biosimilars/follow-on-biologics Market Size and Growth Rate of Monoclonal antibodies from 2016 to 2027

      • 1.3.4 USA Biosimilars/follow-on-biologics Market Size and Growth Rate of Insulin from 2016 to 2027

      • 1.3.5 USA Biosimilars/follow-on-biologics Market Size and Growth Rate of Interferon from 2016 to 2027

      • 1.3.6 USA Biosimilars/follow-on-biologics Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor from 2016 to 2027

      • 1.3.7 USA Biosimilars/follow-on-biologics Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Biosimilars/follow-on-biologics Market Size and Growth Rate of Blood disorders from 2016 to 2027

      • 1.4.2 USA Biosimilars/follow-on-biologics Market Size and Growth Rate of Oncology diseases from 2016 to 2027

      • 1.4.3 USA Biosimilars/follow-on-biologics Market Size and Growth Rate of Chronic and autoimmune diseases from 2016 to 2027

      • 1.4.4 USA Biosimilars/follow-on-biologics Market Size and Growth Rate of Growth hormone deficiencies from 2016 to 2027

      • 1.4.5 USA Biosimilars/follow-on-biologics Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Biosimilars/follow-on-biologics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Biosimilars/follow-on-biologics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Biosimilars/follow-on-biologics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Biosimilars/follow-on-biologics Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Biosimilars/follow-on-biologics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Biosimilars/follow-on-biologics by Major Types

      • 3.4.1 Market Size and Growth Rate of Human growth hormone

      • 3.4.2 Market Size and Growth Rate of Erythropoietin

      • 3.4.3 Market Size and Growth Rate of Monoclonal antibodies

      • 3.4.4 Market Size and Growth Rate of Insulin

      • 3.4.5 Market Size and Growth Rate of Interferon

      • 3.4.6 Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor

      • 3.4.7 Market Size and Growth Rate of Others

    4 Segmentation of Biosimilars/follow-on-biologics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Biosimilars/follow-on-biologics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Biosimilars/follow-on-biologics in Blood disorders

      • 4.4.2 Market Size and Growth Rate of Biosimilars/follow-on-biologics in Oncology diseases

      • 4.4.3 Market Size and Growth Rate of Biosimilars/follow-on-biologics in Chronic and autoimmune diseases

      • 4.4.4 Market Size and Growth Rate of Biosimilars/follow-on-biologics in Growth hormone deficiencies

      • 4.4.5 Market Size and Growth Rate of Biosimilars/follow-on-biologics in Others

    5 Market Analysis by Regions

    • 5.1 USA Biosimilars/follow-on-biologics Production Analysis by Regions

    • 5.2 USA Biosimilars/follow-on-biologics Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Biosimilars/follow-on-biologics Landscape Analysis

    • 6.1 West USA Biosimilars/follow-on-biologics Landscape Analysis by Major Types

    • 6.2 West USA Biosimilars/follow-on-biologics Landscape Analysis by Major End-Users

    7 South USA Biosimilars/follow-on-biologics Landscape Analysis

    • 7.1 South USA Biosimilars/follow-on-biologics Landscape Analysis by Major Types

    • 7.2 South USA Biosimilars/follow-on-biologics Landscape Analysis by Major End-Users

    8 Middle West USA Biosimilars/follow-on-biologics Landscape Analysis

    • 8.1 Middle West USA Biosimilars/follow-on-biologics Landscape Analysis by Major Types

    • 8.2 Middle West USA Biosimilars/follow-on-biologics Landscape Analysis by Major End-Users

    9 Northeast USA Biosimilars/follow-on-biologics Landscape Analysis

    • 9.1 Northeast USA Biosimilars/follow-on-biologics Landscape Analysis by Major Types

    • 9.2 Northeast USA Biosimilars/follow-on-biologics Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Synthon Pharmaceuticals

        • 10.1.1 Synthon Pharmaceuticals Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Teva Pharmaceutical Industries

        • 10.2.1 Teva Pharmaceutical Industries Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Biogen idec

        • 10.3.1 Biogen idec Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Hospira

        • 10.4.1 Hospira Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Merck Serono (Merck)

        • 10.5.1 Merck Serono (Merck) Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Celltrion Biocon

        • 10.6.1 Celltrion Biocon Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Genentech (Roche)

        • 10.7.1 Genentech (Roche) Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 LG Life Sciences

        • 10.8.1 LG Life Sciences Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Novartis (Sandoz)

        • 10.9.1 Novartis (Sandoz) Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Biosimilars/follow-on-biologics Market Size and Growth Rate of Human growth hormone from 2016 to 2027

    • Figure USA Biosimilars/follow-on-biologics Market Size and Growth Rate of Erythropoietin from 2016 to 2027

    • Figure USA Biosimilars/follow-on-biologics Market Size and Growth Rate of Monoclonal antibodies from 2016 to 2027

    • Figure USA Biosimilars/follow-on-biologics Market Size and Growth Rate of Insulin from 2016 to 2027

    • Figure USA Biosimilars/follow-on-biologics Market Size and Growth Rate of Interferon from 2016 to 2027

    • Figure USA Biosimilars/follow-on-biologics Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor from 2016 to 2027

    • Figure USA Biosimilars/follow-on-biologics Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Biosimilars/follow-on-biologics Market Size and Growth Rate of Blood disorders from 2016 to 2027

    • Figure USA Biosimilars/follow-on-biologics Market Size and Growth Rate of Oncology diseases from 2016 to 2027

    • Figure USA Biosimilars/follow-on-biologics Market Size and Growth Rate of Chronic and autoimmune diseases from 2016 to 2027

    • Figure USA Biosimilars/follow-on-biologics Market Size and Growth Rate of Growth hormone deficiencies from 2016 to 2027

    • Figure USA Biosimilars/follow-on-biologics Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Biosimilars/follow-on-biologics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Biosimilars/follow-on-biologics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Biosimilars/follow-on-biologics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Biosimilars/follow-on-biologics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Biosimilars/follow-on-biologics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Biosimilars/follow-on-biologics

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Biosimilars/follow-on-biologics by Different Types from 2016 to 2027

    • Table Consumption Share of Biosimilars/follow-on-biologics by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Human growth hormone

    • Figure Market Size and Growth Rate of Erythropoietin

    • Figure Market Size and Growth Rate of Monoclonal antibodies

    • Figure Market Size and Growth Rate of Insulin

    • Figure Market Size and Growth Rate of Interferon

    • Figure Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Biosimilars/follow-on-biologics by Different End-Users from 2016 to 2027

    • Table Consumption Share of Biosimilars/follow-on-biologics by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Blood disorders

    • Figure Market Size and Growth Rate of Oncology diseases

    • Figure Market Size and Growth Rate of Chronic and autoimmune diseases

    • Figure Market Size and Growth Rate of Growth hormone deficiencies

    • Figure Market Size and Growth Rate of Others

    • Table USA Biosimilars/follow-on-biologics Production by Regions

    • Table USA Biosimilars/follow-on-biologics Production Share by Regions

    • Figure USA Biosimilars/follow-on-biologics Production Share by Regions in 2016

    • Figure USA Biosimilars/follow-on-biologics Production Share by Regions in 2021

    • Figure USA Biosimilars/follow-on-biologics Production Share by Regions in 2027

    • Table USA Biosimilars/follow-on-biologics Consumption by Regions

    • Table USA Biosimilars/follow-on-biologics Consumption Share by Regions

    • Figure USA Biosimilars/follow-on-biologics Consumption Share by Regions in 2016

    • Figure USA Biosimilars/follow-on-biologics Consumption Share by Regions in 2021

    • Figure USA Biosimilars/follow-on-biologics Consumption Share by Regions in 2027

    • Table West USA Biosimilars/follow-on-biologics Consumption by Types from 2016 to 2027

    • Table West USA Biosimilars/follow-on-biologics Consumption Share by Types from 2016 to 2027

    • Figure West USA Biosimilars/follow-on-biologics Consumption Share by Types in 2016

    • Figure West USA Biosimilars/follow-on-biologics Consumption Share by Types in 2021

    • Figure West USA Biosimilars/follow-on-biologics Consumption Share by Types in 2027

    • Table West USA Biosimilars/follow-on-biologics Consumption by End-Users from 2016 to 2027

    • Table West USA Biosimilars/follow-on-biologics Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Biosimilars/follow-on-biologics Consumption Share by End-Users in 2016

    • Figure West USA Biosimilars/follow-on-biologics Consumption Share by End-Users in 2021

    • Figure West USA Biosimilars/follow-on-biologics Consumption Share by End-Users in 2027

    • Table South USA Biosimilars/follow-on-biologics Consumption by Types from 2016 to 2027

    • Table South USA Biosimilars/follow-on-biologics Consumption Share by Types from 2016 to 2027

    • Figure South USA Biosimilars/follow-on-biologics Consumption Share by Types in 2016

    • Figure South USA Biosimilars/follow-on-biologics Consumption Share by Types in 2021

    • Figure South USA Biosimilars/follow-on-biologics Consumption Share by Types in 2027

    • Table South USA Biosimilars/follow-on-biologics Consumption by End-Users from 2016 to 2027

    • Table South USA Biosimilars/follow-on-biologics Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Biosimilars/follow-on-biologics Consumption Share by End-Users in 2016

    • Figure South USA Biosimilars/follow-on-biologics Consumption Share by End-Users in 2021

    • Figure South USA Biosimilars/follow-on-biologics Consumption Share by End-Users in 2027

    • Table Middle West USA Biosimilars/follow-on-biologics Consumption by Types from 2016 to 2027

    • Table Middle West USA Biosimilars/follow-on-biologics Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Biosimilars/follow-on-biologics Consumption Share by Types in 2016

    • Figure Middle West USA Biosimilars/follow-on-biologics Consumption Share by Types in 2021

    • Figure Middle West USA Biosimilars/follow-on-biologics Consumption Share by Types in 2027

    • Table Middle West USA Biosimilars/follow-on-biologics Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Biosimilars/follow-on-biologics Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Biosimilars/follow-on-biologics Consumption Share by End-Users in 2016

    • Figure Middle West USA Biosimilars/follow-on-biologics Consumption Share by End-Users in 2021

    • Figure Middle West USA Biosimilars/follow-on-biologics Consumption Share by End-Users in 2027

    • Table Northeast USA Biosimilars/follow-on-biologics Consumption by Types from 2016 to 2027

    • Table Northeast USA Biosimilars/follow-on-biologics Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Biosimilars/follow-on-biologics Consumption Share by Types in 2016

    • Figure Northeast USA Biosimilars/follow-on-biologics Consumption Share by Types in 2021

    • Figure Northeast USA Biosimilars/follow-on-biologics Consumption Share by Types in 2027

    • Table Northeast USA Biosimilars/follow-on-biologics Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Biosimilars/follow-on-biologics Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Biosimilars/follow-on-biologics Consumption Share by End-Users in 2016

    • Figure Northeast USA Biosimilars/follow-on-biologics Consumption Share by End-Users in 2021

    • Figure Northeast USA Biosimilars/follow-on-biologics Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Synthon Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Synthon Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Synthon Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Synthon Pharmaceuticals

    • Table Product and Service Introduction of Synthon Pharmaceuticals

    • Table Company Profile and Development Status of Teva Pharmaceutical Industries

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries

    • Table Product and Service Introduction of Teva Pharmaceutical Industries

    • Table Company Profile and Development Status of Biogen idec

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen idec

    • Figure Sales and Growth Rate Analysis of Biogen idec

    • Figure Revenue and Market Share Analysis of Biogen idec

    • Table Product and Service Introduction of Biogen idec

    • Table Company Profile and Development Status of Hospira

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hospira

    • Figure Sales and Growth Rate Analysis of Hospira

    • Figure Revenue and Market Share Analysis of Hospira

    • Table Product and Service Introduction of Hospira

    • Table Company Profile and Development Status of Merck Serono (Merck)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck Serono (Merck)

    • Figure Sales and Growth Rate Analysis of Merck Serono (Merck)

    • Figure Revenue and Market Share Analysis of Merck Serono (Merck)

    • Table Product and Service Introduction of Merck Serono (Merck)

    • Table Company Profile and Development Status of Celltrion Biocon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celltrion Biocon

    • Figure Sales and Growth Rate Analysis of Celltrion Biocon

    • Figure Revenue and Market Share Analysis of Celltrion Biocon

    • Table Product and Service Introduction of Celltrion Biocon

    • Table Company Profile and Development Status of Genentech (Roche)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech (Roche)

    • Figure Sales and Growth Rate Analysis of Genentech (Roche)

    • Figure Revenue and Market Share Analysis of Genentech (Roche)

    • Table Product and Service Introduction of Genentech (Roche)

    • Table Company Profile and Development Status of LG Life Sciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of LG Life Sciences

    • Figure Sales and Growth Rate Analysis of LG Life Sciences

    • Figure Revenue and Market Share Analysis of LG Life Sciences

    • Table Product and Service Introduction of LG Life Sciences

    • Table Company Profile and Development Status of Novartis (Sandoz)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis (Sandoz)

    • Figure Sales and Growth Rate Analysis of Novartis (Sandoz)

    • Figure Revenue and Market Share Analysis of Novartis (Sandoz)

    • Table Product and Service Introduction of Novartis (Sandoz)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.